DEXCOM INCDXCM
Market cap
$25.8B
P/E ratio
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Revenue | - | - | - | - | - | - | - | 1,032 | 1,476 | 1,927 | 2,449 | 2,910 | 3,622 | 4,033 |
| Cost of sales | - | - | - | - | - | - | - | 368 | 545 | 647 | 768 | 1,027 | 1,333 | 1,595 |
| Gross profit | 36 | 47 | 100 | 176 | 278 | 378 | 492 | 664 | 932 | 1,280 | 1,681 | 1,883 | 2,289 | 2,438 |
| Research and development | 31 | 40 | 45 | 69 | 138 | 156 | 185 | 200 | 274 | 360 | 517 | 484 | 506 | 552 |
| Selling, general and administrative | 50 | 63 | 84 | 128 | 198 | 286 | 349 | 433 | 516 | 621 | 811 | 1,000 | 1,185 | 1,286 |
| Total operating expenses | 81 | 102 | 129 | 198 | 336 | 442 | 535 | 850 | 789 | 981 | 1,415 | 1,492 | 1,691 | 1,838 |
| Operating income | -45 | -56 | -29 | -21 | -57 | -64 | -42 | -186 | 142 | 300 | 266 | 391 | 598 | 600 |
| Other income (expense), net | 0 | - | - | - | - | -1 | 3 | - | 26 | 16 | -2 | 18 | 113 | 109 |
| Income before income taxes | - | -56 | -30 | -22 | -57 | -65 | -49 | -126 | 104 | 225 | 174 | 391 | 710 | 709 |
| Income tax expense | - | -1 | - | 0 | 0 | 1 | 2 | 1 | 3 | -269 | 19 | 50 | 169 | 133 |
| Net income | -45 | -54 | -30 | -22 | -58 | -66 | -50 | -127 | 101 | 494 | 155 | 341 | 542 | 576 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - | - | 1.11 | 5.23 | 1.6 | 0.88 | 1.4 | 1.46 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | 1.1 | 5.06 | 1.55 | 0.82 | 1.3 | 1.42 |